Lung CancerLUNG-SURG-EDUNCT07614204
Educational Intervention for Patients Undergoing Surgery for Lung Cancer
A study testing Structured Educational Intervention in people with Lung Cancer, run by National and Kapodistrian University of Athens at 1 site in Greece.
Trial summary
The goal of this interventional study is to learn about the effect of a structured educational intervention in patients undergoing surgery for lung cancer. The study will examine whether this intervention can improve patients' acceptance of the disease, quality of life, pain levels, and postoperative clinical and… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Lung Cancer
- What is being tested?
- Structured Educational Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteGreece
- Study dates
- 1 Jan 2021to 1 Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients diagnosed with lung cancer.
- Patients admitted to the referral hospital and undergoing surgical treatment for lung cancer.
- Age older than 18 years.
- Signed written informed consent.
- Ability to speak, understand, and read the Greek language.
- Undisturbed level of consciousness allowing cooperation with the researcher and the healthcare team.
- Ability to participate in a personal interview and complete the study questionnaires.
- Availability of a supportive psychosocial network/caregiver, where required for participation in the educational intervention.
Who cannot join
- Inability to provide written informed consent.
- Inability to speak, understand, or read the Greek language.
- Impaired level of consciousness that prevents cooperation.
- Presence of a chronic condition affecting behavior or ability to cooperate with the study procedures.
- Lack of a supportive psychosocial network.
- Inability to cooperate with the medical and nursing staff.
- Inability to participate in the interview process or complete the required study assessments.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Impact of an Educational Intervention on Disease Acceptance, Quality of Life, Pain Levels, and Postoperative Clinical and Biometric Outcomes Among Patients Undergoing Surgery for Lung Cancer.
The goal of this interventional study is to learn about the effect of a structured educational intervention in patients undergoing surgery for lung cancer. The study will examine whether this intervention can improve patients' acceptance of the disease, quality of life, pain levels, and postoperative clinical and biometric outcomes.
The main question it aims to answer is: Does a structured educational intervention improve disease acceptance, quality of life, pain levels, and postoperative clinical and biometric outcomes in patients undergoing surgery for lung cancer? Participants are assigned to two groups. Participants in the intervention group receive a structured educational intervention in addition to usual care, while participants in the control group receive usual care only. Data are collected through questionnaires and clinical and biometric measurements after surgery, with follow-up assessments over a 5-year period.
Read the detailed description
This is a two-arm parallel-group interventional study evaluating the impact of a structured educational intervention in patients undergoing surgery for lung cancer. The study is conducted at a referral center, where all interviews, educational sessions, follow-up assessments, and data collection procedures take place.
Before enrollment, all eligible patients receive written information about the study and provide written informed consent. By signing the consent form, participants give permission for the researcher to collect study-related data through personal interviews and from their medical records.
Baseline preoperative data are collected from all participants before the delivery of the educational intervention. These data are collected using specially designed questionnaires administered through personal interviews with the patient and include demographic characteristics, hospital admission information, biometric measurements, lifestyle-related factors such as smoking, physical activity, dietary habits and alcohol consumption, as well as personal and family medical history.
Participants are allocated to either an intervention group or a control group. Allocation is performed using a predefined alternating sequence according to the order of surgery. On the first surgical day of the study, the research team determines the initial group assignment for the first eligible participant undergoing the first scheduled surgery. Subsequently, eligible participants are allocated alternately to the intervention and control groups according to the order of surgery. On the next surgical day, the allocation sequence starts with the opposite group, and this alternating pattern continues throughout enrollment.
The intervention group receives usual care plus a structured educational intervention supported by printed educational material. Participation of a caregiver is required during the educational session together with the patient. The printed material includes the date of the educational intervention, the researcher-educator's contact details, and the scheduled follow-up appointment.
The educational intervention includes detailed information about lung cancer and the patient's treatment pathway. Patients are informed about the disease, imaging-based staging, and the possible contribution of histological findings to final disease staging and further treatment planning. Information is also provided about potential adjuvant treatments, including chemotherapy, immunotherapy, and radiotherapy, when clinically indicated.
The intervention also covers the surgical procedure and the expected postoperative course. Patients receive information about postoperative drains, surgical incisions, wound care, mobilization, recovery after surgery, and orientation to the clinical setting. Education is provided on lifestyle modification, including smoking cessation, alcohol use, nutrition, physical activity, exercise after surgery, permitted weight limits, and general self-care during recovery.
In addition, patients are trained in preoperative respiratory exercises to support postoperative respiratory function. A dedicated section focuses on postoperative pain, including pain recognition, pain management strategies, relaxation techniques, and the importance of adequate sleep. Throughout the intervention, patients and their caregivers are encouraged to ask questions, express concerns, and discuss issues related to the disease, surgery, recovery, and follow-up care.
The control group consists of patients in whom the same variables are assessed without receiving the educational intervention. Participants in the control group receive usual clinical care according to the protocol of the Thoracic Surgery Department of the referral center. Interviews and data collection for the control group are also conducted at the referral center. Participants in the control group are reassessed at the same time points as participants in the intervention group.
The first interview and educational session for the intervention group are conducted during the patient's preoperative hospitalization. For both groups, baseline assessment is performed preoperatively. A second interview and educational session for the intervention group are conducted during the first three postoperative days and serve as the first postoperative reassessment. Participants in the control group are reassessed during the same postoperative period without receiving the educational intervention.
Additional follow-up assessments are conducted at the same time points for both groups: at 1 month and 6 months after surgery, after the first postoperative year, and during the planned long-term follow-up period of 5 years.
Patient-reported outcomes are assessed using validated Greek versions of standardized questionnaires. Illness perceptions and disease-related cognition are evaluated using the Illness Cognition Questionnaire for Chronic Diseases, which consists of 18 closed-ended items rated on a four-point scale. The questionnaire assesses three domains: illness acceptance, perceived benefits of the illness, and helplessness related to the illness.
Quality of life is assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) and the lung cancer-specific module EORTC QLQ-LC13, both validated in the Greek language. These instruments assess physical, psychological, and social aspects of quality of life, as well as cancer-related and lung cancer-specific symptoms.
Pain intensity is assessed using the Pain Rating Scale of The British Pain Society. The scale is administered at the predefined study assessment time points in order to monitor postoperative pain and changes in pain levels during follow-up.
Clinical information and biometric measurements are also collected at the predefined assessment time points. Treating physicians and nursing staff are not informed of participants' group allocation.
- Conditions
- Lung Cancer
- Being tested
- Structured Educational Intervention, Usual Care
- Medical subject headings
- Lung Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Structured Educational InterventionBehavioural
The structured educational intervention is delivered to patients undergoing surgery for lung cancer in addition to usual care. It includes printed educational material and individualized education about lung cancer, imaging-based staging, histological findings and final disease staging, possible adjuvant treatments, the surgical procedure, postoperative drains, surgical incisions and wound care, postoperative recovery, respiratory exercises, pain management, relaxation techniques, sleep, lifestyle modification, nutrition, smoking, alcohol use, physical activity, permitted weight limits, and follow-up care. A caregiver is required to participate in the educational session together with the patient.
Usual CareOther
Usual care consists of standard clinical care provided according to the protocol of the Thoracic Surgery Department of the referral center. Participants receiving usual care undergo the same study assessments as the intervention group but do not receive the structured educational intervention.
| Study group | Role | What they receive |
|---|---|---|
| Structured Educational Intervention plus Usual Care | Experimental | Participants in this arm receive a structured educational intervention in addition to usual clinical care. The intervention includes printed educational material and individualized education about lung cancer, surgery, postoperative recovery, respiratory exercises, pain management, lifestyle modification, follow-up care, and self-care. A caregiver is required to participate in the educational session together with the patient. Receives: Behavioral: Structured Educational Intervention |
| Usual Care | Active comparator | Participants in this arm receive usual clinical care according to the protocol of the Thoracic Surgery Department of the referral center. The same variables are assessed at the same time points as in the intervention group, but participants do not receive the structured educational intervention. Receives: Other: Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Disease Acceptance
Disease acceptance is assessed using the validated Greek version of the Illness Cognition Questionnaire for Chronic Diseases. The questionnaire consists of 18 closed-ended items rated on a four-point scale and evaluates three domains: acceptance of the illness, perceived benefits of the illness, and helplessness related to the illness. The primary outcome focuses on changes in the illness acceptance domain between the intervention and control groups over the predefined study assessment time points. The total score for this domain ranges from 6 to 24, with higher scores indicating greater illness acceptance and a better outcome.
Measured: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery
Change in Global Health Status/Quality of Life Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)
Global health status/quality of life will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. The global health status/quality of life scale score ranges from 0 to 100. Higher scores indicate better global health status and better quality of life. Changes in scores will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery
Change in Functional Status Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Functional status will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. The questionnaire includes functional scales assessing physical, role, emotional, cognitive, and social functioning. Each functional scale score ranges from 0 to 100. Higher scores indicate better functioning and therefore a better outcome. Changes in functional scale scores will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.
Change in Cancer-Related Symptoms Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Cancer-related symptoms will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Symptom scales and single-item symptom measures assess symptoms such as fatigue, pain, nausea and vomiting, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties. Each symptom scale or single-item score ranges from 0 to 100. Higher scores indicate greater symptom burden and therefore a worse outcome. Changes in symptom scores will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.
Change in Lung Cancer-Specific Symptoms Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13
Lung cancer-specific symptoms will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13. This lung cancer-specific module assesses symptoms and treatment-related problems, including coughing, hemoptysis, dyspnea, sore mouth, dysphagia, peripheral neuropathy, alopecia, chest pain, arm or shoulder pain, other pain, and pain medication use. Each scale or single-item score ranges from 0 to 100. Higher scores indicate greater symptom burden and therefore a worse outcome. Changes in lung cancer-specific symptom scores will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.
Secondary outcomes (5)
Change in Pain Intensity Assessed by the British Pain Society Numerical Pain Rating Scale
Pain intensity will be assessed using the British Pain Society Numerical Pain Rating Scale. This is an 11-point numerical scale used to evaluate patients' perceived pain intensity. The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain intensity and therefore a worse outcome. Changes in pain intensity scores will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery
Change in Total Cholesterol Levels
Total cholesterol levels will be assessed through blood biochemical analysis. Total cholesterol will be reported in mg/dL. Changes in total cholesterol levels will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery.
Change in Triglyceride Levels
Triglyceride levels will be assessed through blood biochemical analysis. Triglycerides will be reported in mg/dL. Changes in triglyceride levels will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery.
Change in Total Protein Levels
Total protein levels will be assessed through blood biochemical analysis. Total proteins will be reported in g/dL. Changes in total protein levels will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery.
Change in Albumin Levels
Serum albumin levels will be assessed through blood biochemical analysis. Albumin will be reported in g/dL. Changes in albumin levels will be compared between the intervention and control groups over the predefined study assessment time points.
Measured: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 May 2026
- Study start1 Jan 2021
- Primary completion1 Jan 2028 (estimated)
- Study completion1 Jan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lung CancerStudies of the same condition, open and under way.
- More trials run by National and Kapodistrian University of AthensThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- This study used a parallel-group design. Participants in the intervention group received a structured educational intervention in addition to usual care, whereas participants in the control group received usual care alone.
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 160 participants (actual)
Sponsor and investigators
- Lead sponsor
- National and Kapodistrian University of Athens
- Sponsor type
- University, hospital or other
- Collaborators
- Attikon Hospital
- Responsible party
- Principal investigator, Anastasios Moysiadis, National and Kapodistrian University of Athens
- Investigators
- Anastasios Moysiadis, Principal investigator, Medical School, National and Kapodistrian University of Athens; General University Hospital "ATTIKON"
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07614204
- Sponsor's protocol ID
- 678/21-12-2020
- Acronym
- LUNG-SURG-EDU
- Status last verified
- May 2026
- First submitted
- 1 May 2026
- Last updated
- 29 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared due to privacy and confidentiality considerations and because the informed consent does not include permission for sharing individual-level data with external researchers.
Study at a glance
From the registry record, last updated by the sponsor on 29 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of an Educational Intervention on Disease Acceptance, Quality of Life, Pain Levels, and Postoperative Clinical and Biometric Outcomes Among Patients Undergoing Surgery for Lung Cancer.
- ClinicalTrials.gov ID
- NCT07614204
- Acronym / sponsor ID
- LUNG-SURG-EDU / 678/21-12-2020
- Conditions
- Lung Cancer
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 160 participants (actual)
- Lead sponsor
- National and Kapodistrian University of AthensUniversity, hospital or other
- Collaborators
- Attikon Hospital
- Study start
- 1 Jan 2021 (actual)
- Primary completion
- 1 Jan 2028 (estimated)
- Study completion
- 1 Jan 2028 (estimated)
- First posted
- 29 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this interventional study is to learn about the effect of a structured educational intervention in patients undergoing surgery for lung cancer. The study will examine whether this intervention can improve patients' acceptance of the disease, quality of life, pain levels, and postoperative clinical and biometric outcomes.
The main question it aims to answer is: Does a structured educational intervention improve disease acceptance, quality of life, pain levels, and postoperative clinical and biometric outcomes in patients undergoing surgery for lung cancer? Participants are assigned to two groups. Participants in the intervention group receive a structured educational intervention in addition to usual care, while participants in the control group receive usual care only. Data are collected through questionnaires and clinical and biometric measurements after surgery, with follow-up assessments over a 5-year period.
Detailed description
This is a two-arm parallel-group interventional study evaluating the impact of a structured educational intervention in patients undergoing surgery for lung cancer. The study is conducted at a referral center, where all interviews, educational sessions, follow-up assessments, and data collection procedures take place.
Before enrollment, all eligible patients receive written information about the study and provide written informed consent. By signing the consent form, participants give permission for the researcher to collect study-related data through personal interviews and from their medical records.
Baseline preoperative data are collected from all participants before the delivery of the educational intervention. These data are collected using specially designed questionnaires administered through personal interviews with the patient and include demographic characteristics, hospital admission information, biometric measurements, lifestyle-related factors such as smoking, physical activity, dietary habits and alcohol consumption, as well as personal and family medical history.
Participants are allocated to either an intervention group or a control group. Allocation is performed using a predefined alternating sequence according to the order of surgery. On the first surgical day of the study, the research team determines the initial group assignment for the first eligible participant undergoing the first scheduled surgery. Subsequently, eligible participants are allocated alternately to the intervention and control groups according to the order of surgery. On the next surgical day, the allocation sequence starts with the opposite group, and this alternating pattern continues throughout enrollment.
The intervention group receives usual care plus a structured educational intervention supported by printed educational material. Participation of a caregiver is required during the educational session together with the patient. The printed material includes the date of the educational intervention, the researcher-educator's contact details, and the scheduled follow-up appointment.
The educational intervention includes detailed information about lung cancer and the patient's treatment pathway. Patients are informed about the disease, imaging-based staging, and the possible contribution of histological findings to final disease staging and further treatment planning. Information is also provided about potential adjuvant treatments, including chemotherapy, immunotherapy, and radiotherapy, when clinically indicated.
The intervention also covers the surgical procedure and the expected postoperative course. Patients receive information about postoperative drains, surgical incisions, wound care, mobilization, recovery after surgery, and orientation to the clinical setting. Education is provided on lifestyle modification, including smoking cessation, alcohol use, nutrition, physical activity, exercise after surgery, permitted weight limits, and general self-care during recovery.
In addition, patients are trained in preoperative respiratory exercises to support postoperative respiratory function. A dedicated section focuses on postoperative pain, including pain recognition, pain management strategies, relaxation techniques, and the importance of adequate sleep. Throughout the intervention, patients and their caregivers are encouraged to ask questions, express concerns, and discuss issues related to the disease, surgery, recovery, and follow-up care.
The control group consists of patients in whom the same variables are assessed without receiving the educational intervention. Participants in the control group receive usual clinical care according to the protocol of the Thoracic Surgery Department of the referral center. Interviews and data collection for the control group are also conducted at the referral center. Participants in the control group are reassessed at the same time points as participants in the intervention group.
The first interview and educational session for the intervention group are conducted during the patient's preoperative hospitalization. For both groups, baseline assessment is performed preoperatively. A second interview and educational session for the intervention group are conducted during the first three postoperative days and serve as the first postoperative reassessment. Participants in the control group are reassessed during the same postoperative period without receiving the educational intervention.
Additional follow-up assessments are conducted at the same time points for both groups: at 1 month and 6 months after surgery, after the first postoperative year, and during the planned long-term follow-up period of 5 years.
Patient-reported outcomes are assessed using validated Greek versions of standardized questionnaires. Illness perceptions and disease-related cognition are evaluated using the Illness Cognition Questionnaire for Chronic Diseases, which consists of 18 closed-ended items rated on a four-point scale. The questionnaire assesses three domains: illness acceptance, perceived benefits of the illness, and helplessness related to the illness.
Quality of life is assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) and the lung cancer-specific module EORTC QLQ-LC13, both validated in the Greek language. These instruments assess physical, psychological, and social aspects of quality of life, as well as cancer-related and lung cancer-specific symptoms.
Pain intensity is assessed using the Pain Rating Scale of The British Pain Society. The scale is administered at the predefined study assessment time points in order to monitor postoperative pain and changes in pain levels during follow-up.
Clinical information and biometric measurements are also collected at the predefined assessment time points. Treating physicians and nursing staff are not informed of participants' group allocation.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (care provider)
- Number of arms
- 2
- Model description
- This study used a parallel-group design. Participants in the intervention group received a structured educational intervention in addition to usual care, whereas participants in the control group received usual care alone.
| Arm | Type | Receives |
|---|---|---|
| Structured Educational Intervention plus Usual Care | Experimental | Behavioral: Structured Educational InterventionParticipants in this arm receive a structured educational intervention in addition to usual clinical care. The intervention includes printed educational material and individualized education about lung cancer, surgery, postoperative recovery, respiratory exercises, pain management, lifestyle modification, follow-up care, and self-care. A caregiver is required to participate in the educational session together with the patient. |
| Usual Care | Active comparator | Other: Usual CareParticipants in this arm receive usual clinical care according to the protocol of the Thoracic Surgery Department of the referral center. The same variables are assessed at the same time points as in the intervention group, but participants do not receive the structured educational intervention. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Patients diagnosed with lung cancer.
- Patients admitted to the referral hospital and undergoing surgical treatment for lung cancer.
- Age older than 18 years.
- Signed written informed consent.
- Ability to speak, understand, and read the Greek language.
Key exclusion criteria (7 listed)
- Inability to provide written informed consent.
- Inability to speak, understand, or read the Greek language.
- Impaired level of consciousness that prevents cooperation.
- Presence of a chronic condition affecting behavior or ability to cooperate with the study procedures.
- Lack of a supportive psychosocial network.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Structured Educational InterventionThe structured educational intervention is delivered to patients undergoing surgery for lung cancer in addition to usual care. It includes printed educational material and individualized education about lung cancer, imaging-based staging, histological findings and final disease staging, possible adjuvant treatments, the surgical procedure, postoperative drains, surgical incisions and wound care, postoperative recovery, respiratory exercises, pain management, relaxation techniques, sleep, lifestyle modification, nutrition, smoking, alcohol use, physical activity, permitted weight limits, and follow-up care. A caregiver is required to participate in the educational session together with the patient. | Behavioural | Structured Educational Intervention plus Usual Care |
| Usual CareUsual care consists of standard clinical care provided according to the protocol of the Thoracic Surgery Department of the referral center. Participants receiving usual care undergo the same study assessments as the intervention group but do not receive the structured educational intervention. | Other | Usual Care |
Primary outcome
Disease Acceptance
Time frame: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery
Disease acceptance is assessed using the validated Greek version of the Illness Cognition Questionnaire for Chronic Diseases. The questionnaire consists of 18 closed-ended items rated on a four-point scale and evaluates three domains: acceptance of the illness, perceived benefits of the illness, and helplessness related to the illness. The primary outcome focuses on changes in the illness acceptance domain between the intervention and control groups over the predefined study assessment time points. The total score for this domain ranges from 6 to 24, with higher scores indicating greater illness acceptance and a better outcome.
Change in Global Health Status/Quality of Life Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)
Time frame: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery
Global health status/quality of life will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. The global health status/quality of life scale score ranges from 0 to 100. Higher scores indicate better global health status and better quality of life. Changes in scores will be compared between the intervention and control groups over the predefined study assessment time points.
Change in Functional Status Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Time frame: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.
Functional status will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. The questionnaire includes functional scales assessing physical, role, emotional, cognitive, and social functioning. Each functional scale score ranges from 0 to 100. Higher scores indicate better functioning and therefore a better outcome. Changes in functional scale scores will be compared between the intervention and control groups over the predefined study assessment time points.
Change in Cancer-Related Symptoms Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Time frame: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.
Cancer-related symptoms will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Symptom scales and single-item symptom measures assess symptoms such as fatigue, pain, nausea and vomiting, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties. Each symptom scale or single-item score ranges from 0 to 100. Higher scores indicate greater symptom burden and therefore a worse outcome. Changes in symptom scores will be compared between the intervention and control groups over the predefined study assessment time points.
Change in Lung Cancer-Specific Symptoms Assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13
Time frame: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery.
Lung cancer-specific symptoms will be assessed using the validated Greek version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13. This lung cancer-specific module assesses symptoms and treatment-related problems, including coughing, hemoptysis, dyspnea, sore mouth, dysphagia, peripheral neuropathy, alopecia, chest pain, arm or shoulder pain, other pain, and pain medication use. Each scale or single-item score ranges from 0 to 100. Higher scores indicate greater symptom burden and therefore a worse outcome. Changes in lung cancer-specific symptom scores will be compared between the intervention and control groups over the predefined study assessment time points.
5 secondary outcomes
Change in Pain Intensity Assessed by the British Pain Society Numerical Pain Rating Scale
Time frame: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery
Change in Total Cholesterol Levels
Time frame: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery.
Change in Triglyceride Levels
Time frame: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery.
Change in Total Protein Levels
Time frame: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery.
Change in Albumin Levels
Time frame: Baseline preoperative assessment, postoperative Day 1, postoperative Day 2, postoperative Day 3, 1 month, 6 months, 1 year, and annually up to 5 years after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 May 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared due to privacy and confidentiality considerations and because the informed consent does not include permission for sharing individual-level data with external researchers.
Related trials for Lung Cancer
RecruitingEarly Phase 1
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Lung Adenocarcinoma, Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8
Enrolling by invitationObservational study
Screening for Hematology Branch Protocols
Hematologic Disease and Disorders, Donors
RecruitingObservational study
Evaluation for NCI Surgery Branch Clinical Research Protocols
Synovial Cell Cancer, Melanoma
RecruitingPhase 3
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anastasios Moysiadis principal investigator
Medical School, National and Kapodistrian University of Athens; General University Hospital "ATTIKON"
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Structured Educational Intervention in people with Lung Cancer, run by National and Kapodistrian University of Athens at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 29 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Disease Acceptance (time frame: Baseline preoperative assessment, first 3 postoperative days, 1 month, 6 months, 1 year, and up to 5 years after surgery). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2026.